Subscribe Now for Delta3 AI Alerts
Don’t miss out on top stock picks and market insights. Subscribe to Delta3 AI Alerts for real-time updates and expert analysis straight to your inbox. Stay informed and maximize your investment potential.
Key Stats
Key stats represent essential financial metrics and indicators used to evaluate a company's performance and potential investment opportunities.
- Symbol LIMN
- Company Liminatus Pharma, Inc. Class A Common Stock
- Price $0.14
- Changes Percentage -0.84
- Change -0.0012
- Day Low $0.13
- Day High $0.14
- Year High $33.66
- Year Low $0.13
- Market Cap $4,070,628
- Price Avg 50 EMA (D) $0.19
- Price Avg 200 EMA (D) $0.95
- Exchange NASDAQ
- Volume 7,996,094
- Average Volume 10,119,303
- Open $0.14
- Previous Close $0.14
- EPS -0.25
- PE -0.61
- Earnings Announcement 2026-05-15 20:49:34
- Shares Outstanding $26,833,407
Company brief: LIMINATUS PHARMA, INC. CLASS A COMMON STOCK (LIMN )
- Healthcare
- Biotechnology
- Chris Kim
- https://liminatuspharma.com
- US
- N/A
- 05-01-2025
LIMN Corporation News
Liminatus Pharma Enters Into Warrant Exercise Transaction for $1.9 Million in Gross Proceeds
June 3, 2026 at 12:30 pm ET
globenewswire.com -- FULLERTON, Calif., June 03, 2026 (GLOBE NEWSWIRE) -- Liminatus Pharma, Inc. (Nasdaq: LIMN) (“Liminatus” or the “Company”) today announced that it has entered into a warrant exercise agreement ...
